Drotrecogin alfa (activated) -: Treatment of septic shock

被引：1
|
作者：
Sorbera, LA [1 ]
Martín, L [1 ]
Castañer, RM [1 ]
机构：
[1] Prous Sci, Barcelona 08080, Spain
来源：
DRUGS OF THE FUTURE | 2001年 / 26卷 / 05期
关键词：
D O I：
10.1358/dof.2001.026.05.620122
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
[No abstract available]
引用
收藏
页码：440 / 443
页数：4
相关论文
共 50 条
  • [21] Drotrecogin alfa (activated) may attenuate severe sepsis-associated encephalopathy in clinical septic shock
    Herbert Spapen
    Duc Nam Nguyen
    Joris Troubleyn
    Luc Huyghens
    Johan Schiettecatte
    Critical Care, 14
  • [22] Drotrecogin alfa (activated) may attenuate severe sepsis-associated encephalopathy in clinical septic shock
    Spapen, Herbert
    Nguyen, Duc Nam
    Troubleyn, Joris
    Huyghens, Luc
    Schiettecatte, Johan
    CRITICAL CARE, 2010, 14 (02):
  • [23] Practical aspects of treatment with drotrecogin alfa (activated)
    Luigi Camporota
    Duncan Wyncoll
    Critical Care, 11
  • [24] Drotrecogin Alfa (Activated) in the Treatment of Severe Sepsis
    Vincent, Jean-Louis
    CURRENT DRUG SAFETY, 2007, 2 (03) : 227 - 231
  • [25] Drotrecogin Alf (activated) in severe sepsis and septic shock
    Hussain, Aziza Muhammad
    ANAESTHESIA PAIN & INTENSIVE CARE, 2011, 15 (02) : 79 - 80
  • [26] Reversal of refractory septic shock with drotrecogin alpha (activated)
    A. Vieillard-Baron
    V. Caille
    C. Charron
    G. Belliard
    P. Aegerter
    B. Page
    F. Jardin
    Intensive Care Medicine, 2009, 35 : 1204 - 1209
  • [27] Reversal of refractory septic shock with drotrecogin alpha (activated)
    Vieillard-Baron, A.
    Caille, V.
    Charron, C.
    Belliard, G.
    Aegerter, P.
    Page, B.
    Jardin, F.
    INTENSIVE CARE MEDICINE, 2009, 35 (07) : 1204 - 1209
  • [28] Smart Identifies Dichotomous Drotrecogin Alfa Activated Treatment Effects on Mortality in Prowess Shock
    Kelter, David
    Slotman, Gus J.
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2022, 235 (05) : S296 - S296
  • [29] An updated meta-analysis to understand the variable efficacy of drotrecogin alfa (activated) in severe sepsis and septic shock
    Lai, P. S.
    Matteau, A.
    Iddriss, A.
    Hawes, C. L.
    Ranieri, V. M.
    Thompson, B. T.
    MINERVA ANESTESIOLOGICA, 2013, 79 (01) : 33 - 43
  • [30] Initiation of drotrecogin alfa (activated) [DTAA] versus placebo infusion acutely improves hemodynamics in patients with septic shock
    Thomas, Joss J.
    Tidswell, Mark
    Shah, Archan
    Octaviani, Raul
    Kozikowski, Krystal
    Nathanson, Brian
    Steingrub, Jay
    CHEST, 2006, 130 (04) : 149S - 150S
12345